Kenneth Galbraith - Chair & CEO, Director at Zymeworks Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chair & CEO, Director
Issuer Symbol
ZYME on Nasdaq
All Insider Reports
All Insider Reports

Kenneth Galbraith - trading volume in the past year for Zymeworks Inc.

Holdings reported by Kenneth Galbraith for Zymeworks Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 133,275 $3,601,383 $27.02 22 Dec 2025 Direct
Restricted Stock Unit 0 $2,865,427 $14.92 22 Dec 2025 Direct Common Stock
Stock Option (Right to Buy) 288,000 10 Jan 2025 Direct Common Stock

Transactions reported by Kenneth Galbraith for Zymeworks Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.